Market revenue in 2023 | USD 23.9 million |
Market revenue in 2030 | USD 57.0 million |
Growth rate | 13.2% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 57.74% in 2023. Horizon Databook has segmented the Italy mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The mycoplasma testing market in Italy is driven by various factors that contribute to its growth and development. The presence of various cell culture manufacturers, such as Euroclone, Merck KGaA, BioRad Laboratories, Thermo Fisher Scientific, Sartorius, Eppendorf, & others, in the region is driving the demand for mycoplasma testing.
Another key factor for market growth is the robust biopharmaceutical sector in the country. Italy is home to multinational pharmaceutical companies and local biotech firms, which are major end users of the products. With the increasing demand for biopharmaceutical products, the market for testing products and services continues to expand.
Furthermore, the Italian biotech industry exhibited notable growth due to extensive academic & industrial research. Milan is the hub of biotech sector in Italy, housing approximately 35% of all biotech companies.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Italy mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account